Use of L-carnitine or of alkanoyl Lcarnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops

Details for Australian Patent Application No. 2006265248 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

Inventors Pescosolido, Nicola; Koverech, Aleardo

Agent Lord and Company

Pub. Number AU-B-2006265248

PCT Pub. Number WO2007/003481

Priority 05014337.9 01.07.05 EP

Filing date 6 June 2006

Wipo publication date 11 January 2007

Acceptance publication date 15 December 2011

International Classifications

A61K 31/221 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/205 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/04 (2006.01) Drugs for disorders of the senses

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/003481 Priority application(s): WO2007/003481

15 December 2011 Application Accepted

  Published as AU-B-2006265248

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006265249-Method for setting up a multimedia connection in case of cascade connection transfer

2006265245-Synthesis of deoxybiotinyl hexamethylenediamine-DOTA